Other
Income Taxes Receivable Noncurrent
Moderna Income Taxes Receivable Noncurrent remained flat by 0.0% to $161.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 62.6%, from $99.00M to $161.00M.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase suggests higher long-term tax assets or potential future cash inflows from tax authorities.
Detailed definition
This represents tax refunds or credits due to the company from tax authorities that are expected to be realized beyond t...
Peer comparison
Common in capital-intensive industries with complex multi-jurisdictional tax filings.
Metric ID:
other_income_taxes_receivable_noncurrentHistorical Data
6 periods
| Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $97.00M | $99.00M | $99.00M | $99.00M | $161.00M | $161.00M |
| QoQ Change | — | +2.1% | +0.0% | +0.0% | +62.6% | +0.0% |
| YoY Change | — | — | — | — | +66.0% | +62.6% |
Range$97.00M – $161.00M
CAGR+50.0%
Avg YoY Growth+64.3%
Median YoY Growth+64.3%
Current Streak5+ quarters growth
Income Taxes Receivable Noncurrent at Other Companies
Frequently Asked Questions
- What is Moderna's income taxes receivable noncurrent?
- Moderna (MRNA) reported income taxes receivable noncurrent of $161.00M in Q1 2026.
- How has Moderna's income taxes receivable noncurrent changed year-over-year?
- Moderna's income taxes receivable noncurrent increased by 62.6% year-over-year, from $99.00M to $161.00M.
- What does income taxes receivable noncurrent mean?
- Tax refunds or credits expected to be received after more than one year.